Agreement with Redoxis AB
Glucox Biotech announceed today the signing of a contract with Redoxis AB for further studie on Glucox smal molecule NOX4 inhibitors.
Glucox Biotech owns several patents covering the exclusive rights to develop pharmaceutical substances for treating insulin resistance and diabetes on the basis of reducing reactive oxygen species produces by NAD(P)H-oxidase. Redoxis AB is a research company with focused research on autoimmune diseases and with a recognized competence in R&D related to NAD(P)H-oxidase based disease mechanisms. According to the contract Redoxis undertakes to, on a fee-for-service basis, further study the influence of Glucox´ small molecule NOX4 inhibitors on NAD(P)H-oxidase.
https://eroom24.com
hey there and thank you for your information – I have certainly picked up anything new from right here.
I did however expertise a few technical issues using this web site, since
I experienced to reload the site lots of times previous to I
could get it to load correctly. I had been wondering if your hosting is OK?
Not that I’m complaining, but slow loading instances times will
very frequently affect your placement in google and could damage your quality score if ads and marketing with Adwords.
Well I’m adding this RSS to my email and could look out for a lot more of your
respective fascinating content. Make sure you update this again very soon..
Escape room lista
Leticia-P
Very interesting subject, thanks for putting up.?